Lab of the Future

The Lab of the Future Congress USA returns to Boston, March 10-11th, 2025. This is your chance to connect with 500+ life science leaders, explore 35 sessions across 8 specialised tracks, and gain insights into AI, automation, digital transformation and more. Secure your spot now to maximise savings: Super Early Bird Discount: Save up to $600 when you register by Friday. Register here - https://lnkd.in/dq96xTY Highlights: ➡️ Focused Networking: 9 dedicated breaks for fostering collaborations ➡️ Content-led Agenda: Learn from 90+ expert speakers addressing the latest trends and challenges ➡️ Latest Technologies: Hear from and discuss with world-class solution providers ➡️ Interactive Format: Round tables, live Q&As, and audience-led discussions ➡️ Expand your Professional Circle: Connect with delegates before and during the Congress on our event app Additional Group Savings: 3+ Delegates: Save 10% (Code: 3DELS) 6+ Delegates: Save 20% (Code: 6DELS) 10+ Delegates: Save 30% (Code: 10DELS) #LOTF2025 #LaboftheFuture #Innovation #Keynote

We are delighted to announce that Tola Olorunnisola, VP of Strategy, Innovation, Marketing & Digital, Avantor will be a Keynote Speaker at the Lab of the Future Congress USA 2025. In her capacity as GM, Tola’s business unit collaborates closely with scientists and researchers in the lab, offering comprehensive services and digital solutions throughout the scientific process. Her leadership focuses on building a tailored portfolio that delivers operational efficiencies and enhances scientific research to drive groundbreaking discoveries in drug development. Additionally, her unit manages end-to-end supply chain logistics and sample management for various Clinical trials and healthcare applications. With nearly two decades of experience in the Medical Device and Life Science industry, her expertise spans innovation development, strategic and operational execution, enterprise solutions implementation, and business development. Join us for our content-led congress on March 10th and 11th at the Sheraton Boston Hotel, delivering thought leadership via carefully curated sessions. Learn more here: https://lnkd.in/eumFC_p #labofthefuture #innovation #lotf2025

🚨 Speaker Announcement! 🚨 We’re delighted to announce that Christopher Lundy, Senior Principal Enterprise Architect at Pfizer, will be speaking at the Lab of the Future Congress USA 2025! Christopher will share insights in his session: "Smart Labs, Smarter Science: AI and Synthetic Biology in Modern Biopharma" Explore how advanced AI, synthetic biology, and composable architecture are reshaping biopharma R&D, clinical applications, and scientific discovery. With over 20 years of expertise driving enterprise architecture, cloud modernization, and AI-driven solutions, Christopher has spearheaded transformative projects such as: - Modernizing millions of square feet of research labs - Developing digital architecture for a $500M ADC manufacturing plant - Pioneering a Large Language Model revolutionizing drug discovery 📅 Join us March 10-11, 2025 📍 Sheraton Hotels & Resorts Boston Hotel Explore the agenda here: https://lnkd.in/eumFC_p #LabOfTheFuture #Innovation #SmartLabs #AI #SyntheticBiology #Biopharma

Following on from our recent discussion on "How AI and Automation Deliver New Medicines Faster", featuring Thrasyvoulos Karydis, Chief Technology Officer and & Co-Founder, DeepCure and Christos A. Nicolaou, Sr Director, Digital Chemistry, Novo Nordisk, we would like to pose the following question to our Linked In audience: In which area of drug discovery is AI receiving the most investment? - Design - Synthesis - Testing - Analysis Please leave your thoughts in the comments below 👇 #labofthefuture #ai #drugdiscovery

We are delighted to announce that Roberto Padilla, Senior Scientist, Analytical Development and Greg Sjogren, Senior Laboratory Automation Engineer, AbbVie will be speaking at the Lab of the Future Congress USA 2025. Robert and Greg will be addressing the Next Generation High Throughput ELISA Automation Platform at AbbVie. Next-generation high throughput (HT) #ELISA system will increase business productivity and flexibility by increasing efficiency, quality, and throughput via automation of traditional ELISA workflows. The HT ELISA platform is a customized automation solution designed to integrate digital information with enhanced liquid handling technology to perform complex, repetitive, and labour-intensive ELISA workflows. This dynamic approach for ELISA workflows will streamline the acquisition of product impurity data and enable HT experiments for early-to-late phase pipeline programs Roberto is Industry scientist with 7 years of experience in analytical chemistry. Extensive experience in developing analytical methods to characterize biological drug products. Roberto also specializes in automating analytical methods and developing workflows to improve business efficiencies. Greg Sjogren is an Industry veteran with 27 years of experience in biotech and pharma. Extensive background in biology, clinical diagnostics, preclinical pharmacology, instrumentation, assay, and process development, data science, data management, bioinformatics, and laboratory automation. MS in Clinical Research from Drexel University College of Medicine, MSc in Clinical Pathology from University of Massachusetts Lowell, BS in Biology from University of Massachusetts Dartmouth, BA in Technical Writing from Concordia College. Join us for our content-led congress on March 10th and 11th at the Sheraton Boston Hotel, delivering thought leadership via carefully curated sessions. Learn more here: https://lnkd.in/eumFC_p

Happy Thanksgiving from the Lab of the Future Team! As we gather with loved ones and reflect on all we are thankful for, we want to take a moment to express our gratitude to YOU—our followers, collaborators, and the incredible community driving biopharma innovation forward. And if you're still hungry after your meal, feast your eyes on the agenda of our upcoming congress, "stuffed" full of delicious content: https://lnkd.in/eumFC_p Here’s to a holiday filled with celebration, gratitude and community: Happy Thanksgiving! 🧪✨ #HappyThanksgiving #LabOfTheFuture #Innovation

We are delighted to announce that Eric Mabie, Technical Director Lab Technologies, Novartis will be speaking at the Lab of the Future Congress USA 2025. Eric will be speaking on “A Collaborative Approach to Cybersecurity in Novartis's Labs”. Join us for our content-led congress on March 10th and 11th at the Sheraton Boston Hotel, delivering thought leadership via carefully curated sessions. Learn more here: https://lnkd.in/gdcSQff #labofthefuture #lotf2025 #cybersecurity #labtechnologies

Taking place at 3pm GMT today - there's still time to register. https://lnkd.in/eFwbkMgJ #AIinPharma #Automation

It’s your last chance to book on for our next digital dialogue, which takes place tomorrow: Breaking Silos in Drug Discovery: How AI and Automation Deliver New Medicines Faster Drug discovery faces hurdles such as costly manual synthesis and limited success with automation efforts. How can AI and Automation transform this process? 📅 Thursday, 21st November 🕒 16:00 CET · 15:00 GMT · 10:00 EST Thrasyvoulos Karydis, Chief Technology Officer and & Co-Founder, DeepCure Christos A. Nicolaou, Sr Director, Digital Chemistry, Novo Nordisk This free digital dialogue will feature two presentations, followed by a panel discussion and live Q&A. Seats are limited—register now to secure your spot: https://lnkd.in/eFwbkMgJ #DrugDiscovery #AIinPharma #Automation #Webinar #LabOfTheFuture

Join Us for Our Next Digital Dialogue: ▪️ Breaking Silos in Drug Discovery: How AI and Automation Deliver New Medicines Faster Drug discovery faces hurdles such as costly manual synthesis and limited success with automation efforts. How can AI and Automation transform this process? 📅 Thursday, 21st November 🕒 16:00 CET · 15:00 GMT · 10:00 EST 🗣️ Thrasyvoulos Karydis, Christos A. Nicolaou This free digital dialogue will feature two presentations, followed by a panel discussion and live Q&A. 🎯 What You’ll Learn: ▪️ Navigating conflicting objectives in drug discovery for effective treatments. ▪️ A holistic approach to the Design, Make, Test, and Analyze (DMTA) Cycle for efficiency gains. ▪️ Integrating AI molecule design with robotic chemical synthesis. ▪️ Using AI decision-making to overcome production bottlenecks. Seats are limited—register now to secure your spot: https://lnkd.in/eFwbkMgJ Feel free to share this with colleagues who might be interested. We’re looking forward to discussing with you on Thursday! #DrugDiscovery #AIinPharma #Automation #Webinar #LabOfTheFuture